Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.

Dallal CM, Brinton LA, Bauer DC, Buist DS, Cauley JA, Hue TF, Lacroix A, Tice JA, Chia VM, Falk R, Pfeiffer R, Pollak M, Veenstra TD, Xu X, Lacey JV Jr; B~FIT Research Group.

Endocr Relat Cancer. 2013 Feb 18;20(1):151-60. doi: 10.1530/ERC-12-0229. Print 2013 Feb.

2.

Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.

Ashizawa N, Yahata T, Quan J, Adachi S, Yoshihara K, Tanaka K.

Gynecol Oncol. 2010 Oct;119(1):65-9. doi: 10.1016/j.ygyno.2010.07.007. Epub 2010 Aug 2.

PMID:
20674961
3.

Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Luhn P, Dallal CM, Weiss JM, Black A, Huang WY, Lacey JV Jr, Hayes RB, Stanczyk FZ, Wentzensen N, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1304-12. doi: 10.1158/1055-9965.EPI-13-0258. Epub 2013 May 21.

4.

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E, Tjønneland A, Olsen A, Overvad K, Clavel-Chapelon F, Mesrine S, Joulin V, Linseisen J, Rohrmann S, Pischon T, Boeing H, Trichopoulos D, Trichopoulou A, Benetou V, Palli D, Berrino F, Tumino R, Sacerdote C, Mattiello A, Quirós JR, Mendez MA, Sánchez MJ, Larrañaga N, Tormo MJ, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Khaw KT, Bingham S, Allen N, Key T, Jenab M, Riboli E.

J Clin Endocrinol Metab. 2007 Jan;92(1):255-63. Epub 2006 Oct 24.

PMID:
17062769
5.

Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.

Ollberding NJ, Kim Y, Shvetsov YB, Wilkens LR, Franke AA, Cooney RV, Maskarinec G, Hernandez BY, Henderson BE, Le Marchand L, Kolonel LN, Goodman MT.

Cancer Prev Res (Phila). 2013 Mar;6(3):188-95. doi: 10.1158/1940-6207.CAPR-12-0374.

6.

Case-control study of endogenous steroid hormones and endometrial cancer.

Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR.

J Natl Cancer Inst. 1996 Aug 21;88(16):1127-35.

7.

Obesity, adipokines, and prostate cancer in a prospective population-based study.

Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5.

8.

Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.

Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD, Rohan TE, Manson JE, McTiernan A, Kaplan RC, Scherer PE, Chlebowski RT, Snetselaar L, Wang D, Ho GY.

J Natl Cancer Inst. 2015 Jul 16;107(9). pii: djv169. doi: 10.1093/jnci/djv169. Print 2015 Sep.

PMID:
26185195
9.

Insulin and endometrial cancer.

Troisi R, Potischman N, Hoover RN, Siiteri P, Brinton LA.

Am J Epidemiol. 1997 Sep 15;146(6):476-82.

10.

Case-control study of markers of insulin resistance and endometrial cancer risk.

Friedenreich CM, Langley AR, Speidel TP, Lau DC, Courneya KS, Csizmadi I, Magliocco AM, Yasui Y, Cook LS.

Endocr Relat Cancer. 2012 Nov 9;19(6):785-92. doi: 10.1530/ERC-12-0211. Print 2012 Dec.

11.

Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.

Dalamaga M, Karmaniolas K, Papadavid E, Pelekanos N, Sotiropoulos G, Lekka A.

Menopause. 2011 Nov;18(11):1198-204. doi: 10.1097/gme.0b013e31821e21f5.

PMID:
21712732
12.

Plasma adipokines and endometriosis risk: a prospective nested case-control investigation from the Nurses' Health Study II.

Shah DK, Correia KF, Harris HR, Missmer SA.

Hum Reprod. 2013 Feb;28(2):315-21. doi: 10.1093/humrep/des411. Epub 2012 Nov 27.

13.

A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.

Wang T, Rohan TE, Gunter MJ, Xue X, Wactawski-Wende J, Rajpathak SN, Cushman M, Strickler HD, Kaplan RC, Wassertheil-Smoller S, Scherer PE, Ho GY.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):971-7. doi: 10.1158/1055-9965.EPI-10-1222. Epub 2011 Mar 17.

14.

Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.

Gross AL, Newschaffer CJ, Hoffman-Bolton J, Rifai N, Visvanathan K.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1319-24. doi: 10.1158/1055-9965.EPI-12-1444. Epub 2013 May 7.

15.

Adipokines linking obesity with colorectal cancer risk in postmenopausal women.

Ho GY, Wang T, Gunter MJ, Strickler HD, Cushman M, Kaplan RC, Wassertheil-Smoller S, Xue X, Rajpathak SN, Chlebowski RT, Vitolins MZ, Scherer PE, Rohan TE.

Cancer Res. 2012 Jun 15;72(12):3029-37. doi: 10.1158/0008-5472.CAN-11-2771. Epub 2012 Apr 17.

16.

Adiponectin to leptin index as a marker of endometrial cancer in postmenopausal women with abnormal vaginal bleeding: an observational study.

Nowosielski K, Pozowski J, Ulman-Włodarz I, Romanik M, Poręba R, Sioma-Markowska U.

Neuro Endocrinol Lett. 2012;33(2):217-23.

PMID:
22592205
17.

Effects of a walking intervention using mobile technology and interactive voice response on serum adipokines among postmenopausal women at increased breast cancer risk.

Llanos AA, Krok JL, Peng J, Pennell ML, Vitolins MZ, Degraffinreid CR, Paskett ED.

Horm Cancer. 2014 Apr;5(2):98-103. doi: 10.1007/s12672-013-0168-4. Epub 2014 Jan 17.

18.

Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer.

Cymbaluk A, Chudecka-Głaz A, Rzepka-Górska I.

Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):74-7. Epub 2006 Sep 27.

PMID:
17007993
19.

Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.

Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A, Stegger J, Overvad K, Chabbert-Buffet N, Jimenez-Corona A, Clavel-Chapelon F, Rohrmann S, Teucher B, Boeing H, Schütze M, Trichopoulou A, Benetou V, Lagiou P, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Redondo ML, Travier N, Sanchez MJ, Altzibar JM, Chirlaque MD, Ardanaz E, Bueno-de-Mesquita HB, van Duijnhoven FJ, Onland-Moret NC, Peeters PH, Hallmans G, Lundin E, Khaw KT, Wareham N, Allen N, Key TJ, Slimani N, Hainaut P, Romaguera D, Norat T, Riboli E, Kaaks R.

Endocr Relat Cancer. 2010 Oct 29;17(4):1007-19. doi: 10.1677/ERC-10-0053. Print 2010 Dec.

20.

Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.

Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Chang-Claude J, Boeing H, Schulz M, Benetou V, Trichopoulou A, Trichopoulos D, Palli D, Berrino F, Tumino R, Mattiello A, Vineis P, Quirós JR, Agudo A, Sánchez MJ, Larrañaga N, Navarro C, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Bingham S, Khaw KT, Key T, Slimani N, Riboli E, Kaaks R.

Int J Cancer. 2007 Jun 15;120(12):2656-64.

Items per page

Supplemental Content

Write to the Help Desk